Anteris Technologies Ltd (AMEUF)
USD 5.8
(0.0%)
USD 5.8
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.51 Million AUD | -27.13% |
| 2022 | 49.99 Million AUD | 71.46% |
| 2021 | 29.15 Million AUD | 25.32% |
| 2020 | 23.26 Million AUD | -31.32% |
| 2019 | 33.87 Million AUD | -3.01% |
| 2018 | 34.92 Million AUD | 32.76% |
| 2017 | 26.3 Million AUD | -24.65% |
| 2016 | 34.91 Million AUD | 24.4% |
| 2015 | 28.06 Million AUD | 58.92% |
| 2014 | 17.66 Million AUD | 120.72% |
| 2013 | 8 Million AUD | 14.85% |
| 2012 | 6.96 Million AUD | 110.8% |
| 2011 | 3.3 Million AUD | 121.36% |
| 2010 | 1.49 Million AUD | 13.95% |
| 2009 | 1.31 Million AUD | -10.36% |
| 2008 | 1.46 Million AUD | -8.47% |
| 2007 | 1.59 Million AUD | 44.23% |
| 2006 | 1.1 Million AUD | 25.38% |
| 2005 | 883.07 Thousand AUD | 23.45% |
| 2004 | 715.35 Thousand AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 26.62 Million AUD | 0.0% |
| 2024 Q1 | 26.62 Million AUD | 53.84% |
| 2023 Q4 | 17.3 Million AUD | -12.68% |
| 2023 Q2 | 19.12 Million AUD | 18.82% |
| 2023 Q1 | 16.09 Million AUD | 27.89% |
| 2023 Q3 | 19.81 Million AUD | 3.63% |
| 2023 FY | 36.43 Million AUD | -27.13% |
| 2022 Q4 | 12.58 Million AUD | 7.86% |
| 2022 Q2 | 15.06 Million AUD | 31.28% |
| 2022 Q1 | 11.47 Million AUD | 31.0% |
| 2022 FY | 49.99 Million AUD | 71.46% |
| 2022 Q3 | 11.66 Million AUD | -22.55% |
| 2021 Q2 | 5.43 Million AUD | -12.5% |
| 2021 Q1 | 6.21 Million AUD | 18.36% |
| 2021 FY | 29.15 Million AUD | 25.32% |
| 2021 Q3 | 7.61 Million AUD | 40.03% |
| 2021 Q4 | 8.76 Million AUD | 15.1% |
| 2020 Q3 | 5.49 Million AUD | -0.53% |
| 2020 Q2 | 5.52 Million AUD | 34.12% |
| 2020 FY | 23.26 Million AUD | -31.32% |
| 2020 Q4 | 5.24 Million AUD | -4.56% |
| 2020 Q1 | 4.12 Million AUD | -38.42% |
| 2019 FY | 33.87 Million AUD | -3.01% |
| 2019 Q3 | 185.42 Thousand AUD | -96.86% |
| 2019 Q2 | 5.89 Million AUD | -28.48% |
| 2019 Q4 | 6.69 Million AUD | 3509.64% |
| 2019 Q1 | 8.24 Million AUD | -10.89% |
| 2018 Q1 | 8.61 Million AUD | 0.0% |
| 2018 FY | 34.92 Million AUD | 32.76% |
| 2018 Q3 | 9.25 Million AUD | 7.4% |
| 2018 Q2 | 8.61 Million AUD | -0.0% |
| 2018 Q4 | 9.25 Million AUD | 0.0% |
| 2017 Q2 | 5.18 Million AUD | 0.0% |
| 2017 FY | 26.3 Million AUD | -24.65% |
| 2017 Q1 | 5.18 Million AUD | -18.31% |
| 2016 Q3 | 6.34 Million AUD | -11.81% |
| 2016 Q2 | 7.19 Million AUD | 0.0% |
| 2016 FY | 34.91 Million AUD | 24.4% |
| 2016 Q4 | 6.34 Million AUD | 0.0% |
| 2016 Q1 | 7.19 Million AUD | -9.75% |
| 2015 FY | 28.06 Million AUD | 58.92% |
| 2015 Q3 | 7.97 Million AUD | 20.61% |
| 2015 Q2 | 6.61 Million AUD | 0.0% |
| 2015 Q4 | 7.97 Million AUD | -0.0% |
| 2015 Q1 | 6.61 Million AUD | -1.65% |
| 2014 Q2 | 4.42 Million AUD | 0.0% |
| 2014 Q3 | 6.72 Million AUD | 52.08% |
| 2014 FY | 17.66 Million AUD | 120.72% |
| 2014 Q1 | 4.42 Million AUD | 156.35% |
| 2014 Q4 | 6.72 Million AUD | -0.0% |
| 2013 Q1 | 1.13 Million AUD | -46.88% |
| 2013 Q3 | 1.72 Million AUD | 51.32% |
| 2013 FY | 8 Million AUD | 14.85% |
| 2013 Q4 | 1.72 Million AUD | 0.0% |
| 2013 Q2 | 1.13 Million AUD | 0.0% |
| 2012 Q4 | 2.14 Million AUD | -0.0% |
| 2012 FY | 6.96 Million AUD | 110.8% |
| 2012 Q3 | 2.14 Million AUD | 0.0% |
| 2011 FY | 3.3 Million AUD | 121.36% |
| 2010 FY | 1.49 Million AUD | 13.95% |
| 2009 FY | 1.31 Million AUD | -10.36% |
| 2008 FY | 1.46 Million AUD | -8.47% |
| 2007 FY | 1.59 Million AUD | 44.23% |
| 2006 FY | 1.1 Million AUD | 25.38% |
| 2005 FY | 883.07 Thousand AUD | 23.45% |
| 2004 FY | 715.35 Thousand AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AVITA Medical, Inc. | 80.77 Million USD | 96.884% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | -258.063% |
| Össur hf. | 396.18 Million USD | 99.365% |
| QHSLab, Inc. | 961.65 Thousand USD | -161.756% |
| Wellstar International, Inc. | 1.79 Million USD | -40.257% |
| Össur hf. | 396.18 Million USD | 99.365% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 5.25 Million USD | 52.06% |
| Aurora Spine Corporation | 8.65 Million USD | 70.925% |
| BrainsWay Ltd. | 28.01 Million USD | 91.016% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 740.67 Thousand USD | -239.849% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 92.502% |
| Vivos Inc. | 2.78 Million USD | 9.685% |
| Kelyniam Global, Inc. | 2.27 Million USD | -10.633% |
| REMSleep Holdings, Inc. | 1.01 Million USD | -148.022% |
| Zecotek Photonics Inc. | 3.46 Million USD | 27.279% |
| Avitar, Inc. | 3.56 Million USD | 29.481% |
| Nanomix Corporation | 8.36 Million USD | 69.918% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 88.442% |
| Theraclion SA | 7.43 Million USD | 66.166% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1 Million USD | -149.898% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.11 Million USD | 19.073% |
| Lombard Medical, Inc. | 30.29 Million USD | 91.69% |
| ALR Technologies Inc. | 6.33 Million USD | 60.272% |
| Stratec SE | 46.32 Million USD | 94.566% |
| Vycor Medical, Inc. | 1.27 Million USD | -97.354% |
| Heart Tronics, Inc. | 14.46 Million USD | 82.592% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 99.76% |
| VMS Rehab Systems, Inc. | 63.63 USD | -3955867.311% |
| NewCardio, Inc. | 9.56 Million USD | 73.682% |
| Guided Therapeutics, Inc. | 3.49 Million USD | 27.936% |
| Ingen Technologies, Inc. | 1.88 Million USD | -33.735% |
| Odyssey Group International, Inc. | -14.26 Million USD | 117.651% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | -477.998% |
| Wellness Center USA, Inc. | 1.29 Million USD | -94.44% |
| SANUWAVE Health, Inc. | 14.15 Million USD | 82.212% |
| IR-Med Inc. | 4.89 Million USD | 48.566% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -1119.453% |
| Polarean Imaging plc | 12.24 Million USD | 79.439% |
| United American Healthcare Corporation | 59 Thousand USD | -4166.41% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | -517.736% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -1988.497% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | -296.601% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | -48.457% |
| Medical Supply International USA, Inc. | 1.32 Million USD | -90.624% |
| Urologix, Inc. | 10.09 Million USD | 75.058% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | -99.249% |
| Nexeon MedSystems Inc. | 5.94 Million USD | 57.682% |
| SS Innovations International, Inc. | 21.38 Million USD | 88.227% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | -993.281% |
| Smith & Nephew plc | 3.46 Billion USD | 99.927% |
| NIOX Group Plc | 22.27 Million USD | 88.701% |
| Fuse Medical, Inc. | 10.35 Million USD | 75.679% |
| Broncus Holding Corporation | 38.15 Million USD | 93.402% |
| Brain Scientific Inc. | 9.66 Million USD | 73.95% |
| Pressure BioSciences, Inc. | 10.3 Million USD | 75.568% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -4047.059% |